Newsletter

“Favipiravir” reveals the latest research, side effects, who do not take this drug.

Siriraj Clinical Research Center Open usage research report “Favipiravir” (Favipiravir) for PatientsCovid-19 with mild or moderate symptoms which has recommendations about taking the drug Read related news. – Risk of drug resistant bacteria! Thailand uses “Favipiravir” 60 million tablets per month. – side effects favipiravir Warning you shouldn’t cry if you don’t have symptoms of […]

Outpatient treatment for COVID-19 Symptoms-Procedures to receive services

March 1, 2022, the Ministry of Public Health has increased the “outpatient (OPD)” care options for COVID-19 patients in the green syndrome group and has no risk factors that will exacerbate the symptoms. It is an adjustment of the system according to the symptoms. In which “Omicron” over 90% have no symptoms or have few […]

“Omicron” in March, stable but careful to attack the elderly

(28 Feb. 2022), Dr. Kiatpoom Wongrachit, Permanent Secretary, Ministry of Public Health State progress statement Coronavirus disease 2019 issues, guidelines for the treatment of coronavirus patients “Omicron species” that now “Omicron” Epidemic is the main species. Although the infection was 10 times higher, the mortality rate was lower than that of the Delta species outbreak. […]

Drugs to treat COVID-19, Favipiravir, Provincial Administration Organization, produce, procure, develop, sufficient for long-term use

At the Coronavirus Disease News Operation Center 2019, Ministry of Public Health, Nonthaburi Province (May 19, 2020), Dr. Nuntakan, Ph.D. Suwanpitakakul Specialist Pharmaceutical Organization (GPO) said that the Pharmaceutical Organization A management plan has been made to provide the necessary medicines for the treatment of patients infected with the 2019 coronavirus disease or disease.Covid-19 (COVID-19) […]